| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-09-08 21:50 Tx date 2026-03-19 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-50,000 vol |
0 | |
| Filed 2026-09-08 21:49 Tx date 2025-08-07 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-300,000 vol |
50,000 | |
| Filed 2026-09-08 21:44 Tx date 2024-04-01 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-4,000 vol |
185,700 | |
| Filed 2026-09-08 21:43 Tx date 2022-07-06 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+200 vol |
592,700 | |
| Filed 2026-09-08 21:42 Tx date 2022-04-04 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-12,500 vol |
592,500 | |
| Filed 2026-09-08 21:42 Tx date 2022-03-31 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-5,000 vol |
605,000 | |
| Filed 2026-09-08 21:41 Tx date 2022-01-24 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-30,000 vol |
610,000 | |
| Filed 2026-09-08 21:41 Tx date 2022-01-17 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-400,000 vol |
640,000 | |
| Filed 2026-09-08 21:40 Tx date 2022-01-14 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-400,000 vol |
1,040,000 | |
| Filed 2026-08-20 15:19 Tx date 2026-03-19 |
$GENX
Genix Pharmaceuticals Corporation |
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-50,000 vol |
350,000 | |
| Filed 2026-08-20 15:18 Tx date 2021-03-19 |
$GENX
Genix Pharmaceuticals Corporation |
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
350,000 | |
| Filed 2026-08-17 22:37 Tx date 2020-12-30 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$336,318
+6,726,373 vol $0.05 each |
9,525,746 | |
| Filed 2020-12-31 16:40 Tx date 2020-12-30 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$340,086
+6,801,737 vol $0.05 each |
||
| Filed 2026-07-31 14:11 Tx date 2021-01-01 |
$GENX
Genix Pharmaceuticals Corporation |
Union Venture Trading S.A.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
9,173,671 | ||
| Filed 2025-09-09 17:58 Tx date 2025-09-05 |
$GENX
Genix Pharmaceuticals Corporation |
Mahmoud, Aziz
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+1,000,000 vol |
1,000,000 | |
| Filed 2025-09-09 17:57 Tx date 2021-05-19 |
$GENX
Genix Pharmaceuticals Corporation |
Mahmoud, Aziz
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-09-09 17:57 Tx date 2025-09-05 |
$GENX
Genix Pharmaceuticals Corporation |
Mahmoud, Aziz
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$50,000
+1,000,000 vol $0.05 each |
7,419,671 | |
| Filed 2025-09-09 17:55 Tx date 2025-09-05 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+1,000,000 vol |
1,000,000 | |
| Filed 2025-09-09 17:55 Tx date 2018-08-27 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-09-09 17:54 Tx date 2025-09-05 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$50,000
+1,000,000 vol $0.05 each |
1,891,300 |